
- Pharmaceutical Commerce - May/June 2017
Marken launches 24-hour patient call center
UPS-owned subsidiary expands its direct-to-patient clinical services
Claiming to have the first such service in the clinical logistics industry, Marken (RTP, NC) has started a call center service to coordinate drop-offs and pickups for clinical trial subjects. With the PIC in place, clinical trial sponsors could choose, for example, to write direct-to-patient instructions into the trial protocol, thus providing a higher level of overall trial quality management. When such direct-to-patient services occur in patients’ homes, home-nursing organizations are often involved; Marken says that it will coordinate with those as well. The 24/7/365 call center, called a Patient Interaction Center (PIC), is based in Philadelphia, and case managers are trained in the specialized logistics needs of clinical trial protocols, which need to be followed very exactly to maintain data quality of the trial.
“We have embraced the industry’s focus on patient-centric clinical trials and now consider ourselves a leader in direct to patient services,” said Wes Wheeler, Marken CEO, in a statement. "Marken pioneered direct to patient services five years ago and since then we have gained the trust of our clients because of our commitment to the patient, their confidentiality, and compliance with local data protection laws.”
Direct-to-patient is also an increasingly important component of commercial drug distribution, as specialty products such as biologics in prefilled syringes go direct to patients, especially in chronic care. That is generally the realm of
The service is limited to the US only at this time, although a company spokesperson notes that internationalization could be a natural next step, since Marken makes deliveries in 150 countries, and operates a network of 45 depots and logistics centers around the world. In turn, Marken’s parent, UPS Healthcare Logistics,
Articles in this issue
over 8 years ago
The sales rep study I’d like to seeover 8 years ago
Survey tracks evolving health economics function in pharmaover 8 years ago
Is your corporate board equipped to monitor incentive programs?over 8 years ago
2017 Product Security Reportover 8 years ago
Compliance Package of the Year goes to Merck’s Zepatierover 8 years ago
How cloud-based IT systems address FDA validation requirementsover 8 years ago
Future look: The Impact of Biosimilars on Oncologyover 8 years ago
New science energizes the cancer marketover 8 years ago
A Conversation with John Chiminski, CatalentNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.